APA (7th ed.) Citation

ML, B., H, W., D, F., Z, R., GP, M., T, B., . . . D, D. (2021). Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis. Frontiers in oncology, 11, 749064. https://doi.org/10.3389/fonc.2021.749064

Chicago Style (17th ed.) Citation

ML, Bastacky, et al. "Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis." Frontiers in Oncology 11 (2021): 749064. https://doi.org/10.3389/fonc.2021.749064.

MLA (9th ed.) Citation

ML, Bastacky, et al. "Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis." Frontiers in Oncology, vol. 11, 2021, p. 749064, https://doi.org/10.3389/fonc.2021.749064.